Chemical Structure (Lidocaine 01)
Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0409-4276
29 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-4276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lidocaine 01a
Chemical structure of Lidocaine Hydrochloride, showing a benzene ring with two methyl groups and a side chain including an amide and a tertiary amine, associated with hydrochloride and water molecules.*
Hospira Logo (Lidocaine 02)
Principal Display Panel (5 mL Ampule Label)
Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) solution in a 5 mL vial. The label states it is preservative-free and for prescription use only, distributed by Hospira, Inc. The label includes an NDC number 0409-4713-12 and the Hospira logo.*
Principal Display Panel (5 mL Ampule Cello Pack Label)
Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) solution, showing dosage of 50 mg/5 mL in 5 mL single-dose ampuls. The preservative-free product is distributed by Hospira, Inc., made in Spain, for human prescription use. It includes instructions for infiltration and nerve block routes.*
Principal Display Panel (2 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection, USP showing strength of 1% (20 mg/2 mL, equivalent to 10 mg/mL). The 2 mL solution is preservative-free. Distributed by Hospira, Inc., with NDC 0409-4713-72. Marked for human prescription use only.*
Principal Display Panel (5 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) solution in a 5 mL vial. The label states it is preservative-free, distributed by Hospira, Inc., Lake Forest, IL, and is for prescription use only. NDC number 0409-4713-75 is shown along with placeholders for lot number and expiration date.*
Principal Display Panel (2 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection, USP 20 mg/2 mL (equivalent to 10 mg/mL) preservative-free solution. The label shows a 2 mL vial size, distributed by Hospira, Inc., Lake Forest, IL, USA. The label includes lot and expiration date fields and features the Hospira logo.*
Principal Display Panel (2 mL Ampule Carton)
Packaging label for Lidocaine HCl Injection, USP 20 mg/2 mL (10 mg/mL) solution in 2 mL single-dose ampuls. The product is preservative-free and indicated for infiltration and nerve block including epidural and caudal use. The labeler is Hospira, Inc., and the label includes storage instructions along with the NDC 0409-4713-25 and barcode information.*
Principal Display Panel (50 mL Vial Label)
Label for Lidocaine Hydrochloride Injection, USP 0.5% (5 mg/mL) preservative-free solution, 50 mL single-dose vial providing 250 mg per vial. Distributed by Hospira, Inc., Lake Forest, IL. The label lists product use for infiltration, perineural injection, and intravenous regional anesthesia with dosage details and storage instructions included.*
Principal Display Panel (50 mL Vial Tray)
Packaging label for Lidocaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 50 mL single-dose teartop vial. The label indicates a total of 250 mg per 50 mL vial, preservative-free, with instructions for infiltration technique, distributed by Hospira, Inc. The label includes storage instructions and aseptic use guidelines.*
Principal Display Panel (30 mL Vial Label)
Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) preservative-free solution in a 30 mL single-dose vial. The label indicates a total of 300 mg per 30 mL. It is distributed by Hospira, Inc. and intended for infiltration and nerve block use. The label includes NDC 0409-4279-16 and storage instructions.*
Principal Display Panel (30 mL Vial Tray)
Packaging label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) in a 30 mL single-dose teartop vial. The label indicates it is preservative-free, for infiltration and nerve block including epidural and caudal, and is Rx only. It is distributed by Hospira, Inc.*
Principal Display Panel (20 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection, USP 1.5% solution with 15 mg/mL strength in a 20 mL single-dose vial. The label indicates it is preservative-free, Rx only, for infiltration and nerve block including epidural and caudal use. Distributed by Hospira, Inc., Lake Forest, IL. Storage instructions and lot/expiration placeholders are also visible.*
Principal Display Panel (20 mL Ampule Carton)
Packaging label for Lidocaine HCl Injection, USP 300 mg/20 mL (15 mg/mL) in 20 mL single-dose ampuls. The preservative-free solution is labeled for infiltration and nerve block, including epidural and caudal use. The labeler is Hospira, Inc., with storage and ingredient details provided on the label.*
Principal Display Panel (2 mL Ampule Label)
Label for Lidocaine Hydrochloride Injection USP 2% solution, containing 40 mg per 2 mL (20 mg/mL) in a 2 mL single-dose vial. The product is preservative-free and labeled as Rx only. Distributed by Hospira, Inc., Lake Forest, IL.*
Principal Display Panel (2 mL Ampule Cello Pack)
Label for Lidocaine Hydrochloride Injection, USP 20 mg/mL (2% solution) in a 2 mL single-dose ampul. The label states it is preservative-free and lists Hospira, Inc. as the labeler. It includes usage information, storage conditions, and a barcode.*
Principal Display Panel (10 mL Ampule Label)
The label is for Lidocaine Hydrochloride Injection, USP 2% solution, with a strength of 200 mg/10 mL (20 mg/mL). It is a single-dose 10 mL vial, preservative-free, for infiltration and nerve block including epidural and caudal use. The label notes the active ingredient concentration and dosing details, distributed by Hospira, Inc., Lake Forest, IL, USA.*
Principal Display Panel (10 mL Ampule Carton)
Packaging label for Lidocaine HCl Injection, USP 2% (20 mg/mL) 200 mg/10 mL in 10 mL single-dose ampuls. The label states preservative-free and specifies use for infiltration and nerve blocks including epidural and caudal. Distributed by Hospira, Inc. The label includes barcode, NDC 0409-4282-02, and storage instructions.*
Principal Display Panel (400 mg/20 mL Vial Label)
Label of Lidocaine Hydrochloride Injection, USP 2% solution, 400 mg/20 mL (20 mg/mL) in a 20 mL multiple-dose vial. The label states it is for infiltration and nerve block, not for epidural and caudal use, and contains preservative. Distributed by Hospira, Inc., Lake Forest, IL. The label includes lot number and expiration date placeholders.*
Principal Display Panel (400 mg/20 mL Vial Tray)
Packaging label for Lidocaine HCl Injection, USP 2% (20 mg/mL) in a 20 mL multiple-dose fliptop vial. The label states the strength as 400 mg/20 mL and notes it is for infiltration and nerve block. It includes a warning that the product is not for epidural and caudal use and contains preservatives. The labeler is Hospira, Inc., with storage instructions and lot number details. The label also includes a barcode and NDC numbers.*
Principal Display Panel (1000 mg/50 mL Vial Label)
Label for Lidocaine Hydrochloride 2% Injection, USP, 1000 mg/50 mL (20 mg/mL) solution. It is a multiple-dose vial for infiltration and nerve block, not for epidural or caudal use, containing preservative. The label includes dosage composition, storage instructions, and manufacturer Hospira, Inc.*
Principal Display Panel (1000 mg/50 mL Vial Tray)
Packaging label for Lidocaine HCl 2% Injection, USP, Lidocaine Hydrochloride injection solution at 20 mg/mL strength. The label specifies a 50 mL multiple-dose fliptop vial container holding 1000 mg per vial, intended for infiltration and nerve block. It includes warnings against epidural and caudal use, and notes it contains a preservative. The labeler is Hospira, Inc.*
Principal Display Panel (200 mg/20 mL Vial Label)
Lidocaine HCl Injection, USP 1% solution, 200 mg/20 mL (10 mg/mL) in a 20 mL multiple-dose vial. The label indicates use for infiltration and nerve block, with cautions against epidural and caudal use. Contains preservatives and storage instructions at 20 to 25°C. Distributed by Hospira, Inc.*
Principal Display Panel (200 mg/20 mL Vial Tray)
Carton label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL), 20 mL multiple-dose flitop vials, providing a total of 200 mg per 20 mL vial. It is indicated for infiltration and nerve block, with warnings against epidural and caudal use. The labeler is Hospira, Inc. The label includes storage instructions, ingredient information, and barcode with NDC 0409-4276-01.*
Principal Display Panel (500 mg/50 mL Vial Label)
Label of Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) multiple-dose vial containing 50 mL (500 mg total). The label states it is for infiltration and nerve block use, not for epidural and caudal use, and contains preservatives. Distributed by Hospira, Inc., Lake Forest, IL.*
Principal Display Panel (500 mg/50 mL Vial Tray)
Packaging label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in a 50 mL multiple-dose fliptop vial. The label indicates a total of 500 mg per 50 mL, for infiltration and nerve block, with a warning that it is not for epidural and caudal use. The labeler is Hospira, Inc. The label includes storage instructions and a barcode.*
Principal Display Panel (250 mg/50 mL Vial Label)
Label for Lidocaine Hydrochloride Injection, USP 0.5% (5 mg/mL) multiple-dose 50 mL vial. The label states the product is for infiltration and nerve block only, not for epidural or caudal use, and contains preservatives. Distributed by Hospira, Inc., Lake Forest, IL. Includes dosage and storage instructions, NDC 0409-4275-16.*
Principal Display Panel (250 mg/50 mL Vial Tray)
Packaging label for Lidocaine Hydrochloride Injection USP 0.5% (5 mg/mL) by Hospira, Inc. The label indicates a 50 mL multiple-dose fliptop vial with a total of 250 mg per vial. It is intended for infiltration and nerve block and contains preservatives. Storage instructions and handling precautions are also noted on the label.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
